Biopharma News
🇪🇺 EMAEMA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 13 articles
EU Pharma Package exclusivity timelines: what innovators can do now
China Becomes Big Pharma's Essential R&D Partner
Owkin and AstraZeneca Enhance AI Collaboration for Drug Research
European Navenibart Deal: A Strategic Win for BioCryst's Rare Disease Portfolio
SERB Pharmaceuticals Acquires European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma AB
BioPharma Clinical Trials EU: Daily Insights
Elanco's Negasunt and Tanidil Receive FDA Emergency Authorization for New World Screwworm Treatment in Livestock
Pharma 2026: Key Takeaways from EU Biopharma & Medtech
EMA Recommends First RNA-Based Veterinary Vaccine Nobivac NXT HCPChFeLV for Cats
Pet Service Holding Reports 2025 Annual Results Amid European Veterinary Regulatory Changes
EU BioPharma Clinical Trials: Key Oncology Data at ASCO & AUA
Healthcare Logistics Market to Surge $159.91 Billion by 2030, Driven by Biopharmaceutical Growth and Cold Chain Expansion